PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Nov-2022 BC Platforms Announces USD 20 Million Growth Financing led by Jolt Capital B3C newswire
08-Nov-2022 Global Self-healing Materials market is reviewed competitive landscape, current advancements, And Forecast Period 2022-2031  Wired Release
08-Nov-2022 Global Antibiotics market gives In-depth Analysis And Forcest 2022-2031 Wired Release
08-Nov-2022 ​​​​​​​Eckert & Ziegler: Nine-Month Figures Show Strong Sales Growth Eckert & Ziegler Strahlen- und Medizintechnik AG
08-Nov-2022 Pupillometer Market projected moderate-paced CAGR of 7.7% during the forecast period | Future Market Insights MARKITWIRED
08-Nov-2022 Infertility Market Is Anticipated To Register Around 12.5% CAGR From 2022-2031 Wired Release
08-Nov-2022 Medical Membranes Market Is Anticipated To Register Around 10.15% CAGR From 2022-2031 Wired Release
08-Nov-2022 Insulin Pen Market to Exhibit a Decent CAGR of 8.8% by 2031 Wired Release
08-Nov-2022 Tissue Engineering Market to Reflect Tremendous Growth Potential With A CAGR Of 14.6% BY 2031 Wired Release
08-Nov-2022 Wheelchairs Market to reach a valuation of US$ 7.9 Bn by the year 2032, Says Future Market Insights MARKITWIRED
08-Nov-2022 Mobile Clinics Market anticipated to achieve a worth of US$ 8.1 billion by the end of 2032 | FMI MARKITWIRED
08-Nov-2022 Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. further extend their stay of pending litigation to provide additional time for the parties to finalize their litigation settlement Relief Therapeutics Holding SA
08-Nov-2022 Protein Expression Market - How The Market Will Witness Substantial Growth In The Upcoming Years Markets and Markets
08-Nov-2022 Humana Prices $1.25 Billion Debt Offering Businesswire
08-Nov-2022 Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order Businesswire
08-Nov-2022 AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase Businesswire
08-Nov-2022 Teva to Present Latest Research from the CONNECT1 and CONNECT2 Clinical Trials at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting Businesswire
08-Nov-2022 Marinus Pharmaceuticals Announces Proposed Public Offering Businesswire
08-Nov-2022 Athersys, Inc. Announces Proposed Public Offering Businesswire
08-Nov-2022 Fabrinet Announces First Quarter Fiscal Year 2023 Financial Results Businesswire